ARCH Venture Partners

Portfolio companies

ARCH Venture Partners is on record against 7 companies.

Agios Pharmaceuticals Denali Therapeutics Grail Illumina Juno Therapeutics Twist Bioscience Vir Biotechnology

Investment focus

ARCH Venture Partners invests across all stages, from seed to growth, focusing on deep tech and life sciences globally, with a strong U.S. presence. Their portfolio spans sectors like biotech, quantum computing, and advanced materials, targeting transformative scientific breakthroughs.

Related investors

+ND Capital Fund (f.k.a. NanoDimension)Also backs Twist Bioscience
F-Prime Capital (fka Fidelity Biosciences)Also backs Denali Therapeutics
Drive CapitalAlso backs Grail
F-PrimeAlso backs Denali Therapeutics
7wire VenturesAlso invests at the seed and growth stages

All investors with a sourced record →

Get a deep full report on ARCH Venture Partners → Get warm-intro paths to ARCH Venture Partners → See how VCs use MentionFox →

Public profile · MentionFox — investor research, warm-intro mapping, and full reports.